The chemical class designated as TRAV2 Activators encompasses a variety of compounds that can activate T cells with TRAV2-containing TCRs by modulating intracellular signaling pathways integral to T cell function. These activators are known for their roles in influencing key signaling molecules and pathways that are universally involved in the regulation of T cell activation. The activation of T cells, including those expressing TRAV2, is a tightly regulated process that involves a cascade of intracellular events, such as the activation of protein kinase C (PKC), changes in intracellular calcium concentration, and the regulation of transcription factors like NFAT (nuclear factor of activated T-cells).
These compounds can alter the activity of enzymes like serine/threonine phosphatases, which play a critical role in controlling the phosphorylation status of proteins involved in T cell receptor signaling. Moreover, they can modulate the activity of critical kinases within the T cell, such as mTOR, which is a central regulator of cell growth and metabolism. By acting on these enzymes, TRAV2 Activators can influence the signaling thresholds required for T cell activation. In addition to kinase regulation, some of these activators can modulate second messenger systems, such as those involving cAMP or calcium, which are essential for the transduction of signals from the T cell surface to the nucleus. Furthermore, TRAV2 Activators can impact the function of small GTPases by affecting the prenylation process, which is essential for their localization and activity within the cell. The regulation of these small GTPases by TRAV2 Activators can, in turn, influence the cytoskeletal rearrangements and the formation of the immunological synapse, a critical step in effective T cell signaling. Collectively, these actions underscore the complex nature of T cell activation and the broad range of targets that TRAV2 Activators can influence within the cell. The activation of T cells is a critical component of the immune response, and the modulation of these signaling pathways by TRAV2 Activators reflects the intricate interplay of cellular processes that underpin T cell function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), a part of the TCR signaling pathway, which could possibly activate T cells with TRAV2 TCRs. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin serves as a calcium ionophore, raising intracellular calcium levels, a key step that could possibly activate T cells with TRAV2 TCRs. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, leading to inhibition of NFAT activation, a process that could possibly activate T cells with TRAV2 TCRs when disrupted. | ||||||
FK-506 | 104987-11-3 | sc-24649 sc-24649A | 5 mg 10 mg | $78.00 $151.00 | 9 | |
FK506 binds FKBP12, inhibiting calcineurin, and could possibly activate T cells with TRAV2 TCRs by altering NFAT pathway regulation. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
By inhibiting protein phosphatases PP1 and PP2A, okadaic acid affects signaling pathways that could possibly activate T cells with TRAV2 TCRs. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
This PKC inhibitor could possibly activate T cells with TRAV2 TCRs by modulating the PKC pathway involved in T cell activation. | ||||||
Sotrastaurin | 425637-18-9 | sc-474229 sc-474229A | 5 mg 10 mg | $300.00 $540.00 | ||
By inhibiting PKC, sotrastaurin could possibly activate T cells with TRAV2 TCRs, as PKC is vital for TCR signaling. | ||||||
Prostratin | 60857-08-1 | sc-203422 sc-203422A | 1 mg 5 mg | $141.00 $541.00 | 24 | |
Prostratin activates PKC and could possibly activate T cells with TRAV2 TCRs by influencing downstream signaling pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
This cAMP analog activates PKA, which could possibly activate T cells with TRAV2 TCRs through modulation of TCR signaling. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR, a regulator of T cell activation, and could possibly activate T cells with TRAV2 TCRs by affecting this pathway. | ||||||